• Facebook
  • Rss
  • Twitter
  • Youtube
  • Store
  • Donate
  • 0Shopping Cart
NCCS - National Coalition for Cancer Survivorship
  • About
    • Our Mission
    • Our History
    • Our Leadership
      • Policy Advisors
    • Employment
    • Partnerships
    • Financial Information
  • Policy
    • Quality Cancer Care
    • Access to Care
    • Health Equity
    • Redefining Functional Status (RFS)
    • 2020 State of Cancer Survivorship Survey
    • Cancer Care Planning and Communications Act (CCPCA)
  • Get Involved
    • What is Advocacy?
    • Cancer Policy and Advocacy Team (CPAT)
    • Elevating Survivorship
    • Survivor Stories
    • Cancerversary
    • State Based Cancer Advocacy
  • Resources
    • Survivorship Checklist
    • Cancer Survival Toolbox
    • Telehealth
    • Publications
      • Talking With Your Doctor
      • Self Advocacy
      • Employment Rights
      • Remaining Hopeful
    • Taking Charge of Your Care
    • Care Planning for Cancer Survivors
    • Tools For Care Providers
    • COVID-19 Resources for Cancer Survivors
    • Order Our Resources
  • News
    • Cancer Convos Podcast
  • Events
    • Ellen L. Stovall Award
      • 2020 Stovall Awards
      • Honorees
      • Sponsors
      • Committees
      • Reception
      • Nominations
    • Cancer Policy Roundtable
      • Fall 2020 Cancer Policy Roundtable
      • Spring 2020 Cancer Policy Roundtable
    • Cancer Policy and Advocacy Team (CPAT) Symposium 2020
    • Webinars
  • Contact Us
  • Search
  • Menu Menu

Year-End MATCH (DEADLINE Dec 31): Donate & Make a Difference | Donate

ChildhoodCancerActionDayshgherres

A New Addition to Our Policy Team: Kelsey Nepote’s First Assignment with Alliance for Childhood Cancer Action Days

July 2, 2014/in Cancer News, Cancer Policy Blog, NCCS News Quality Cancer Care, Survivorship Care NCCS News /by actualize
Kelsey and Berk

“My niece was diagnosed with Acute Lymphocytic Leukemia at the age of five in October 2013. Her diagnosis was the impetus for me to seek out a position in an organization that would allow me to influence the delivery system of cancer care and advocate for cancer survivors and their families.”

On Monday of last week it was with great pleasure that I started in my new position at NCCS as Policy and Advocacy Manager. My first assignment was to attend the Alliance for Childhood Cancer Action Days, which NCCS first reported on in June. This two-day event had significant meaning to me personally as my niece was diagnosed with Acute Lymphocytic Leukemia at the age of five in October 2013. Her diagnosis was the impetus for me to seek out a position in an organization that would allow me to influence the delivery system of cancer care and advocate for cancer survivors and their families.

During the first day, parents, children, family members, and other advocates gathered together for training and presentations focused on one critical issue, the need for increased funding for pediatric cancer research. The pediatric cancer field is in serious need of new discoveries in treatment and other innovations in care. For example, when compared to advances in adult cancer drug development, very few drugs have been approved to treat children with cancer and even fewer have been developed specifically to treat children with cancer. Astonishingly, over the last 20 years only one drug has been approved for any childhood cancer. While the tone in the room was heavy with loss and frustration, there were several stories of hope but few of progress.

On day two, advocates took to Capitol Hill and made two requests of congressional offices—co-sponsor the Caroline Pryce Walker Conquer Childhood Cancer Reauthorization Act (H.R. 2607/S. 1251) and support appropriating $5.26 billion to the National Cancer Institute (NCI) in FY 2015. Originally enacted in 2008, the Caroline Pryce Walker Conquer Childhood Cancer Reauthorization Act would expand the research of childhood cancers, improve efforts to identify and track childhood cancer incidences, and identify opportunities to expand the development and research of therapeutics. The NCI budget has remained flat over the last 10 years but when accounting for inflation, the budget has decreased by more than $1.1 billion since 2003, seriously compromising its purchasing power. In addition, due to a lack of private industry funding, federal funding is particularly crucial as the NCI provides virtually all of the funding for pediatric cancer research.

Throughout the congressional visits I had the privilege of escorting a couple to the six offices of the Kansas delegation, my home state, and hear them tell their story of their son Chase who was diagnosed with stage three embryonal rhabdomyosarcoma in his back at four weeks old. Because rhabdomyosarcoma in the paraspinal muscles is rare, Chase’s oncologist regularly participated in conversations with other pediatric oncologists through the Children’s Oncology Group (COG), an NCI supported clinical trials group, to determine the best treatment plan. Chase’s treatment lasted 18 months and included a resection surgery that removed many vertebra and ribs. Despite Chase’s devastating diagnosis and treatment plan, he is currently three years post-treatment with no signs of cancer. His parents are incredibly grateful for the treatment that saved their son’s life but they are fully aware that he will have life-long complications and limitations due to his treatment that could impact his quality of life. Chase’s parents are looking for significant advances in pediatric cancer research in hopes that no other child will be subject to the harsh treatments Chase experienced.

Post by Kelsey Nepote

Childhood Cancer Action Day

Tags: Cancer Survivorship, childhood cancer, patient first, quality
Share this entry
  • Share on Facebook
  • Share on Twitter
https://canceradvocacy.org/wp-content/uploads/2014/07/ChildhoodCancerActionDayshgherres.jpg 150 150 actualize https://canceradvocacy.org/wp-content/uploads/2020/06/NCCA-Logo.png actualize2014-07-02 10:19:412020-10-22 08:43:05A New Addition to Our Policy Team: Kelsey Nepote’s First Assignment with Alliance for Childhood Cancer Action Days
You might also like
NCCS Starburst 250px Health Care Roundup: NCCS COVID-19 Webinars & Podcast; Paid Leave for Vulnerable Patients; Resources for Finding Coverage; “Chemo Brain” Study; More
Scott Gottlieb NCCS Statement on Nomination of Dr. Scott Gottlieb for FDA Commissioner
Different Treatment Options Require WCOE: Different Treatment Options Require Consideration of Patient Preferences, and What We Can Learn from Price Transparency in Veterinary Medicine
Evidence-Based Medicine WCOE: Ethics and Discussions about Patient Goals and Preferences, Evidence-Based Medicine
Exercise nutrition Moving Through and Beyond Stage IV Colorectal Cancer
docandpatient WCOE: Challenges of Care Coordination in a Fragmented Health Care System
Eligibility to Cancer Survivors NCCS Applauds Resolution to Block Short-Term Insurance Plans, Protect Those with Pre-Existing Conditions
Ellen headshot B Vice President Joe Biden’s Tribute to Ellen Stovall’s Legacy

Latest News

HHS Humphrey bldg 1200

NCCS, Cancer Groups Urge CMS to Withdraw Most Favored Nation (MFN) Medicare Part B Rule That Will Harm Patients and Reduce Access to Care

December 22, 2020
The National Coalition for Cancer Survivorship (NCCS) joined other member organizations…
Read more
https://canceradvocacy.org/wp-content/uploads/2017/10/HHS-Humphrey-bldg-1200.jpg 600 1200 NCCS Staff https://canceradvocacy.org/wp-content/uploads/2020/06/NCCA-Logo.png NCCS Staff2020-12-22 20:27:262021-01-04 21:38:15NCCS, Cancer Groups Urge CMS to Withdraw Most Favored Nation (MFN) Medicare Part B Rule That Will Harm Patients and Reduce Access to Care
NCCS Letter to HHS

NCCS Letter to HHS: Proposed Regulatory Review Rule Would Create Unnecessary Uncertainty for Patients

December 9, 2020
The National Coalition for Cancer Survivorship (NCCS) recently submitted comments…
Read more
https://canceradvocacy.org/wp-content/uploads/HHS-Humphrey-bldg-1200-1030x515-1.jpg 515 1030 NCCS Staff https://canceradvocacy.org/wp-content/uploads/2020/06/NCCA-Logo.png NCCS Staff2020-12-09 17:30:502020-12-10 08:22:55NCCS Letter to HHS: Proposed Regulatory Review Rule Would Create Unnecessary Uncertainty for Patients
HHS Humphrey bldg 1200

NCCS Opposes Most Favored Nation (MFN) Rule: New Medicare Part B Drug Payment Model Will Harm Patients

December 3, 2020
The National Coalition for Cancer Survivorship (NCCS) opposes the Most Favored Nation…
Read more
https://canceradvocacy.org/wp-content/uploads/HHS-Humphrey-bldg-1200.jpg 600 1200 NCCS Staff https://canceradvocacy.org/wp-content/uploads/2020/06/NCCA-Logo.png NCCS Staff2020-12-03 21:26:462020-12-03 21:28:06NCCS Opposes Most Favored Nation (MFN) Rule: New Medicare Part B Drug Payment Model Will Harm Patients

Take Action

Stovall Award

The Ellen L. Stovall Award for Innovation in Patient-Centered Cancer Care is a unique opportunity for patients and survivors to recognize pioneers who are transforming the cancer care system.

Join CPAT

The NCCS Cancer Policy & Advocacy Team (CPAT) is a program for survivors and caregivers to learn about pressing policy issues that affect quality cancer care in order to be engaged as advocates in public policy around the needs of cancer survivors.

Share Your Story

NCCS represents the millions of Americans who share a common experience – the survivorship experience – living with, through and beyond a cancer diagnosis.

STAY CONNECTED

Together we can improve cancer care for survivors! Sign up to be the first to know about cancer policy issues and ways to take action

  • About
    • Our Mission
    • Our History
    • Our Leadership
      • Policy Advisors
    • Employment
    • Partnerships
    • Financial Information
  • Policy
    • Quality Cancer Care
    • Access to Care
    • Health Equity
    • Redefining Functional Status (RFS)
    • 2020 State of Cancer Survivorship Survey
    • Cancer Care Planning and Communications Act (CCPCA)
  • Get Involved
    • What is Advocacy?
    • Cancer Policy and Advocacy Team (CPAT)
    • Elevating Survivorship
    • Survivor Stories
    • Cancerversary
    • State Based Cancer Advocacy
  • Resources
    • Survivorship Checklist
    • Cancer Survival Toolbox
    • Telehealth
    • Publications
      • Talking With Your Doctor
      • Self Advocacy
      • Employment Rights
      • Remaining Hopeful
    • Taking Charge of Your Care
    • Care Planning for Cancer Survivors
    • Tools For Care Providers
    • COVID-19 Resources for Cancer Survivors
    • Order Our Resources
  • News
    • Cancer Convos Podcast
  • Events
    • Ellen L. Stovall Award
      • 2020 Stovall Awards
      • Honorees
      • Sponsors
      • Committees
      • Reception
      • Nominations
    • Cancer Policy Roundtable
      • Fall 2020 Cancer Policy Roundtable
      • Spring 2020 Cancer Policy Roundtable
    • Cancer Policy and Advocacy Team (CPAT) Symposium 2020
    • Webinars
  • Contact Us

National Coalition for Cancer Survivorship
8455 Colesville Road  |  Suite 930  |  Silver Spring, MD 20910
877-NCCS-YES  |  info@canceradvocacy.org
Privacy Policy  |  Terms and Conditions

Copyright © 1995-2021 by the National Coalition for Cancer Survivorship
National Coalition for Cancer Survivorship, NCCS, Cancer Survival Toolbox, and related Logos are registered in the United States as trademarks of the National Coalition for Cancer Survivorship.

WCOE: Childhood Cancer Action Day, NCCS Provides Patient Perspective at IOM... Childhood Cancer Action Day ACA Progress Report WCOE: Pediatric Cancer Survivorship Challenges and an ACA Progress Report
Scroll to top

Harmar Brereton, MD

Founder
Northeast Regional Cancer Institute

 

“Perhaps one of the most impactful collaborations in Dr. Brereton’s extraordinary career remains his early work and long friendship with Ellen Stovall. Through him, and in turn through the thousands of lives he has touched, Ellen’s work continues, and her mission lives on.”

—Karen M. Saunders
President, Northeast Regional Cancer Institute